Abstract
Since we introduced cultured dorsal root ganglia (DRG) neurons from streptozotocin (STZ)-induced diabetic mice as "an in vitro model to study diabetic neuropathy" (Sotelo et al., 1991), more than 30 papers have been devoted to the study of diabetic neuropathy with culture systems of neurons and Schwann cells derived from adult animals. So far, methods for dissociated cell culture of peripheral neurons (mainly DRG neurons) and Schwann cells, and for explant culture of peripheral ganglia and retinas have been applied to diabetic animals or patients. In addition to these diabetic cells, adult animal neurons and Schwann cells cultured under high glucose conditions and adult animal neurons exposed to diabetic serum have been utilized. The findings from these culture models clearly show that the exposure of mature neurons and Schwann cells to hyperglycemic conditions in vivo or in vitro can alter their biophysical and biochemical properties (e.g., cell viability, neurite outgrowth activity, polyol metabolism and electrophysiological features). Therefore, the cultured neurons and Schwann cells can be useful tools for investigating the precise mechanisms leading to diabetic neuropathy and the efficacy of therapeutic agents for the prevention and treatment of that condition.
Keywords: Diabetic neuropathy, Adult animal neurons and Schwann cells, Dissociated cell culture, Explant culture
Current Diabetes Reviews
Title: Cultured Adult Animal Neurons and Schwann Cells Give Us New Insights into Diabetic Neuropathy
Volume: 2 Issue: 2
Author(s): Kazunori Sango, Haruhiro Saito, Masahiko Takano, Akiko Tokashiki, Shuji Inoue and Hidenori Horie
Affiliation:
Keywords: Diabetic neuropathy, Adult animal neurons and Schwann cells, Dissociated cell culture, Explant culture
Abstract: Since we introduced cultured dorsal root ganglia (DRG) neurons from streptozotocin (STZ)-induced diabetic mice as "an in vitro model to study diabetic neuropathy" (Sotelo et al., 1991), more than 30 papers have been devoted to the study of diabetic neuropathy with culture systems of neurons and Schwann cells derived from adult animals. So far, methods for dissociated cell culture of peripheral neurons (mainly DRG neurons) and Schwann cells, and for explant culture of peripheral ganglia and retinas have been applied to diabetic animals or patients. In addition to these diabetic cells, adult animal neurons and Schwann cells cultured under high glucose conditions and adult animal neurons exposed to diabetic serum have been utilized. The findings from these culture models clearly show that the exposure of mature neurons and Schwann cells to hyperglycemic conditions in vivo or in vitro can alter their biophysical and biochemical properties (e.g., cell viability, neurite outgrowth activity, polyol metabolism and electrophysiological features). Therefore, the cultured neurons and Schwann cells can be useful tools for investigating the precise mechanisms leading to diabetic neuropathy and the efficacy of therapeutic agents for the prevention and treatment of that condition.
Export Options
About this article
Cite this article as:
Sango Kazunori, Saito Haruhiro, Takano Masahiko, Tokashiki Akiko, Inoue Shuji and Horie Hidenori, Cultured Adult Animal Neurons and Schwann Cells Give Us New Insights into Diabetic Neuropathy, Current Diabetes Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339906776818613
DOI https://dx.doi.org/10.2174/157339906776818613 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NF-κB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway
Current Neurovascular Research Relative Survival Benefit and Morbidity with Fluids in Severe Sepsis - A Network Meta-Analysis of Alternative Therapies
Current Drug Safety Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Genetic Variations and Subclinical Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
Current Vascular Pharmacology Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology From Endothelial Dysfunction to Arterial Stiffness in Diabetes Mellitus
Current Diabetes Reviews Herbal Medications for the Management of Diabetes Mellitus: A Review
Current Traditional Medicine Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Editorial (Hot Topic: Synthetic, Natural and Related Compounds: New Approach to Chronic Diseases Studies)
Current Topics in Medicinal Chemistry Beta-cell Specific Autoantibodies: Are they Just an Indicator of Type 1 Diabetes?
Current Diabetes Reviews Editorial: Limited Utility of the Handgrip Test for the Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy: “There’s Time Enough, But None to Spare”
Current Vascular Pharmacology Multiple Roles of Transient Receptor Potential (TRP) Channels in Inflammatory Conditions and Current Status of Drug Development
Current Topics in Medicinal Chemistry The Glutamatergic Neurotransmission in the Central Nervous System
Current Medicinal Chemistry Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Evaluation of the Fibromyalgia and Related Risk Factors in Patients with Advanced Kidney Failure Undergoing Hemodialysis
Current Rheumatology Reviews Diabetic Gastroenteropathy: Soothe the Symptoms or Unravel a Cure?
Current Diabetes Reviews Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Current Enzyme Inhibition Metabolic Therapy of Heart Failure
Current Pharmaceutical Design Involvement of L-Carnitine in Cellular Metabolism: Beyond Acyl-CoA Transport
Mini-Reviews in Medicinal Chemistry